Skip to content

Advertisement

  • Research
  • Open Access

Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men

  • †1Email author,
  • †1,
  • 2,
  • 3,
  • 1,
  • 1,
  • 1,
  • 1,
  • 4,
  • 5,
  • 3 and
  • 1
†Contributed equally
Diabetology & Metabolic Syndrome20146:27

https://doi.org/10.1186/1758-5996-6-27

©  Yagi et al.; licensee BioMed Central Ltd. 2014

  • Received: 20 October 2013
  • Accepted: 19 February 2014
  • Published:

Abstract

Background

A high-calorie diet and physical inactivity, an imbalance between caloric intake and energy consumption, are major causes of metabolic syndrome (MetS), which manifests as accumulation of visceral fat and insulin resistance. However, the lifestyle-related factors associated with visceral fat mass in healthy men are not fully understood.

Methods

We evaluated visceral fat area (VFA), skeletal muscle mass, caloric intake, and energy expenditure in 67 healthy male participants (mean age, 36.9 ± 8.8 years; body mass index 23.4 ± 2.5 kg/m2).

Results

Multiple regression analysis showed that the total skeletal muscle mass (P < 0.001) were negatively and age (P < 0.001) were positively associated with VFA. Lower limb muscle mass (P < 0.001) was strongly associated with VFA. However, total caloric intake, total energy expenditure, and energy expenditure during exercise were not associated with VFA.

Conclusions

Skeletal muscle mass especially lower limb muscle mass negatively contributes to visceral fat mass in healthy men. Therefore, maintaining lower limb muscular fitness through daily activity may be a useful strategy for controlling visceral obesity and metabolic syndrome.

Keywords

  • Exercise
  • Skeletal muscle
  • Metabolic syndrome
  • Prevention

Introduction

The imbalance between caloric intake and energy consumption, high-calorie diets and physical inactivity, are major causes of metabolic syndrome (MetS), which manifests as accumulation of visceral fat and insulin resistance [1]. The prevention of MetS is an important issue, as it is a major cause of cardiovascular disease (CVD) [2, 3].

Lifestyle intervention including caloric restriction and exercise is the preferred approach to reduce the incidence of MetS [4, 5]. Exercise not only increases energy consumption but also improves muscle metabolism through increased glucose uptake in skeletal muscles [6]. In addition, exercise enhances skeletal muscle mass, suggesting that skeletal muscle mass could be a parameter of exercise duration and intensity. Exercise prevents visceral obesity [7]; however, the relashonship between viseral obesity and skeletal muscle mass remains unclear.

The American Heart Association therefore recommends weight reduction to a BMI of <25 kg/m2) with exercise duration of at least 30 min performed 5 times a week at moderate intensity [1]; however, it is unclear which exercise should be used and which skeletal muscles should be targeted to effectively reduce visceral fat mass in healthy subjects. Since the prevalence of MetS is increasing worldwide, healthy subjects are potentially at risk of MetS [8–10]. Therefore, it is important to identify the risk factors for visceral fat obesity in healthy subjects to prevent MetS. In order to clarify these issues, we evaluated visceral fat mass, skeletal muscle mass, caloric intake, and energy consumption in healthy Japanese men and identified lifestyle-related factors associated with visceral fat mass.

Methods

We recruited 67 healthy male volunteers aged between 20 and 85 years (mean age, 36.9 ± 8.8 years; body mass index (BMI) 23.4 ± 2.5 kg/m2). Visceral fat area (VFA) and subcutaneous fat area (SFA) were measured using a fat area analyzer (Dual Scan HDS-2000®; Omron, Japan) [11, 12]. Studies have shown that the correlation coefficient between VFA measured by the fat area analyzer and VFA measured by computed tomography was r = 0.88 (p < 0.001) [12]. The repeatability of the fat area analyzer was evaluated by the Bland–Altman plot, which has been described elsewhere [12]. These data indicate that this indirect measurement of VFA has a high correlation coefficient with VFA evaluated by computed tomography and does not involve X-ray exposure. Because VFA and SFA were compared with obesity-related variables, which were adjusted with body size represented by body surface area or body weight, VFA and SFA were indexed with body surface area (BSA) as visceral fat area index (VFAI) and subcutaneous fat area index (SFAI), respectively. Skeletal muscle mass was measured with a body composition analyzer (Inbody 7200®; Biospace, Korea) [13]. Body weight and waist circumstance were measured, and BMI was calculated as an index of obesity.

Energy expenditure and total caloric intake was calculated using a questionnaire for food and exercise frequency. Energy expenditure during exercise was defined as energy consumed during exercise per day. Total energy expenditure was defined as energy consumed for daily activity, which includes energy expenditure during exercise. Total caloric intake, energy expenditure during exercise, and total energy expenditure were assessed for 7 days. These values were then averaged per day [14, 15].

The study protocol was approved by the Ethics Committee at the Tokushima University Hospital.

Statistical analysis

For continuous variables, each value is expressed as the mean ± SD. Single regression analysis was used to assess the correlation between VFA and obesity-related parameters. The degree of association among independent variables, including VFAI, age, skeletal muscle mass, energy expenditure, caloric intake, and parts of skeletal muscles, was assessed by multiple regression analyses (stepwise regression model). All statistical analyses were performed using SPSS software. Statistical significance was defined as P < 0.05.

Results

Clinical characteristics of subjects

The clinical characteristics of the subjects are presented in Table 1.
Table 1

Clinical characteristics of subjects

Variables (n = 67)

Mean ± SD

Age (years)

36.9 ± 8.8

BW (kg)

69.2 ± 8.3

BMI (kg/m2)

23.4 ± 2.5

Waist circumference (cm2)

84.2 ± 7.4

VFA (cm2)

75.0 ± 29.5

VFAI (cm2)

41.0 ± 14.7

SFA (cm2)

160.3 ± 56.9

SFAI (cm2)

87.6 ± 27.7

Fat weight (kg)

15.1 ± 5.3

Fat weight/BW (%)

21.5 ± 5.6

Skeletal muscle weight

 

Total body (kg)

30.4 ± 3.0

Total body/BW(%)

44.3 ± 0.03

Upper limbs, (kg)

5.8 ± 0.7

Upper limbs/BW, (%)

8.3 ± 0.7

Lower limbs (kg)

17.5 ± 1.9

Lower limbs/BW (%)

25.5 ± 2.3

Truncal muscle (kg)

7.1 ± 0.9

Truncal muscle/BW (%)

10.3 ± 1.3

BW, body weight; BMI, body mass index; VFA, visceral fat area; VFAI, visceral fat area index; SFA, subcutaneous fat area; SFAI, subcutaneous fat area index.

VFAI is inversely associated with skeletal muscle mass and energy expenditure

The VFAI was positively associated with waist circumference, BMI, SFAI (Figure 1), and age (Figure 2), but was negatively associated with upper, lower and total skeletal muscle mass (Figure 2). The SFAI was negatively associated with total skeletal muscle mass (Figure 2). Neither SFAI nor skeletal muscle mass was associated with age (data not shown).
Figure 1
Figure 1

Waist circumference, BMI, and SFA are associated with VFA. VFA: visceral fat area, BMI: body mass index, SFA: subcutaneous fat area, BSA: body surface area.

Figure 2
Figure 2

Age is positively associated with increased VFA, while total skeletal muscle mass is negatively associated with both VFA and SFA. Upper and lower skeletal muscle mass are negatively associated with VFA. VFA: visceral fat area, SFA: subcutaneous fat area, BSA: body surface area, BW: body weight.

The VFAI was negatively associated with total energy expenditure and energy expenditure during exercise (Figure 3), but there was no relationship between total caloric intake and VFAI (data not shown).
Figure 3
Figure 3

Total energy expenditure for daily-life activity and energy expenditure during exercise are negatively associated with increased VFA. VFA: visceral fat area, BSA: body surface area, BW: body weight.

Stepwise multiple regression analysis showed that total skeletal muscle mass was a negative and age was a positive determinant of VFAI; however, total caloric intake, total energy expenditure, and energy expenditure during exercise were statistically excluded (Table 2).
Table 2

Multiple regression analysis for determinants of visceral fat area

Variables

Coefficient

95% Confidence interval

Standardized coefficient

P value

Total skeletal muscle mass

−295

−404 to −187

−0.51

<0.001

Age

0.63

0.32 to 0.94

0.38

<0.001

R2 = 0.45, P < 0.001.

VFAI is inversely associated with lower limb skeletal muscle mass

In order to clarify which part of skeletal muscle, including upper limb, lower limb, and truncal skeletal muscle, influences the volume of visceral fat, we performed stepwise multiple regression analysis. Although lower limb skeletal muscle mass was a negative and age was a positive determinant of VFA, upper limb and truncal skeletal muscle mass were statistically excluded (Table 3).
Table 3

Multiple regression analysis for determinants of visceral fat area

Variables

Coefficient

95% Confidence interval

Standardized coefficient

P value

Age

0.52

0.20 to 0.84

0.31

<0.01

Lower limb muscle weight

−6.78

−9.19 to −4.36

−0.53

<0.001

Upper limb muscle weight

-

-

-

-

Truncal muscle weight

-

-

-

-

R2 = 0.46, P < 0.001.

Discussion

The lifestyle-related factors associated with visceral fat mass has been unknown. In this study, we showed that skeletal muscle mass especially lower limb muscle mass are negatively associated with VFAI.

We showed that the VFAI is positively associated with age and negatively associated with skeletal muscle mass. VFA is positively associated with number of metabolic risk factors in the elderly [16], and skeletal muscle mass is inversely associated with age [17, 18]. However, our data showed that skeletal muscle mass was not associated with age, which is supported by the evidence that muscular strength is inversely associated with the incidence of MetS, independently of age [19]. Although the age outliers might have affected the results (Additional file 1), they nevertheless indicate that the decrease in skeletal muscle mass can be prevented by physical activity.

Decreased skeletal muscle mass leads to physical inactivity [20]. Conversely, physical inactivity leads to decreased skeletal muscle mass [20]. Decreased skeletal muscle mass and strength is associated with increased morality [21, 22]. Sarcopenic obesity is also associated with hypertension, independent of abdominal obesity [23]. Increasing skeletal muscle mass and strength via daily exercise may therefore prevent MetS and prolong life span.

In addition, in patients with metabolic syndrome, visceral fat accumulation is accompanied by excess lipid deposition in skeletal muscle, which may contribute to impaired glucose uptake leading to insulin resistance [24]. Improved skeletal muscle functions (including metabolic system) through exercise may contribute to the prevention of MetS [25].

The American Heart Association recommends daily exercise to prevent the accumulation of abdominal fat [1]. Although some subjects exercised in their spare time, our results showed that the association between total energy expenditure during daily activity and VFAI was stronger than the association between energy expenditure during exercise and VFAI. Because the duration of energy expenditure during exercise is relatively short, it may be insufficient for reducing VFA. Therefore, the length of continuous caloric consumption is important for reducing VFA. Enhanced energy expenditure combined with daily exercise is essential for reducing the volume of visceral fat.

Lower limb muscle mass is a determinant of VFAI. Lower limb muscle including the quadriceps forms the largest muscle mass in the body and may therefore contribute to decreased VFA to a greater extent than upper limb or truncal muscle. Lower limb muscle mass and performance in gait are also important because they are associated with reduced mobility, a poor quality of life, CVD, and death [26–28]. Increased physical activity and daily lower body exercise (e.g., brisk walking, cycling, and stair climbing) may be the most useful way to reduce visceral fat and improve mortality. Increased daily activity in young- and middle-aged men may prevent MetS and CVD by decreasing the volume of visceral fat.

In conclusion, skeletal muscle mass especially lower limb muscle mass negatively contributed to VFA in healthy men. Maintaining lower limb muscular fitness through daily exercise may therefore be a useful strategy for controlling visceral obesity and MetS.

Consent

Informed consent was obtained from the participants for the publication of this report and any accompanying images.

Notes

Abbreviations

MetS: 

Metabolic syndrome

CVD: 

Cardiovascular disease

VFA: 

Visceral fat area

SFA: 

Subcutaneous fat area

BMI: 

Body mass index

BSA: 

Body surface area

VFAI: 

Visceral fat area index

SFAI: 

Subcutaneous fat area index.

Declarations

Acknowledgments

This work was supported in part by JSPS KAKENHI Grant Number 25461131.

Authors’ Affiliations

(1)
Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan
(2)
Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan
(3)
Department of Rehabilitation, Tokushima University Hospital, Tokushima, Japan
(4)
Department of Medical Education, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan
(5)
Department of Cardio-Diabetes Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan

References

  1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.View ArticlePubMedGoogle Scholar
  2. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444: 881-887. 10.1038/nature05488.View ArticlePubMedGoogle Scholar
  3. Matsuzawa Y: Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006, 3: 35-42. 10.1038/ncpcardio0380.View ArticlePubMedGoogle Scholar
  4. Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van Gaal L: The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013, 8: e56415-10.1371/journal.pone.0056415.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Case CC, Jones PH, Nelson K, O’Brian Smith E, Ballantyne CM: Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002, 4: 407-414. 10.1046/j.1463-1326.2002.00236.x.View ArticlePubMedGoogle Scholar
  6. Richter EA, Hargreaves M: Exercise, glut4, and skeletal muscle glucose uptake. Physiol Rev. 2013, 93: 993-1017. 10.1152/physrev.00038.2012.View ArticlePubMedGoogle Scholar
  7. Ismail I, Keating SE, Baker MK, Johnson NA: A systematic review and meta-analysis of the effect of aerobic vs. Resistance exercise training on visceral fat. Obes Rev. 2012, 13: 68-91. 10.1111/j.1467-789X.2011.00931.x.View ArticlePubMedGoogle Scholar
  8. Grundy SM: Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008, 28: 629-636. 10.1161/ATVBAHA.107.151092.View ArticlePubMedGoogle Scholar
  9. Mozumdar A, Liguori G: Persistent increase of prevalence of metabolic syndrome among U.S. Adults: Nhanes iii to nhanes 1999–2006. Diabetes Care. 2011, 34: 216-219. 10.2337/dc10-0879.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE: Metabolic syndrome: recent prevalence in east and southeast asian populations. Asia Pac J Clin Nutr. 2007, 16: 362-367.PubMedGoogle Scholar
  11. Ida M, Hirata M, Odori S, Mori E, Kondo E, Fujikura J, Kusakabe T, Ebihara K, Hosoda K, Nakao K: Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction. Obesity. 2013, 21: E350-E353.PubMedGoogle Scholar
  12. Shiga T, Hamaguchi , Oshima Y, Kanai H, Hirata M, Hosoda K, Nakao K: A new simple measurement system of visceral fat accumulation by bioelectrical impedance analysis. IFMBE Proc. 2009, 25 (VII): 338-341.View ArticleGoogle Scholar
  13. Jensky-Squires NE, Dieli-Conwright CM, Rossuello A, Erceg DN, McCauley S, Schroeder ET: Validity and reliability of body composition analysers in children and adults. Br J Nutr. 2008, 100: 859-865.View ArticlePubMedGoogle Scholar
  14. Hollowell RP, Willis LH, Slentz CA, Topping JD, Bhakpar M, Kraus WE: Effects of exercise training amount on physical activity energy expenditure. Med Sci Sports Exerc. 2009, 41: 1640-1644. 10.1249/MSS.0b013e31819c71a4.View ArticlePubMedGoogle Scholar
  15. Reilly JJ, Jackson DM, Montgomery C, Kelly LA, Slater C, Grant S, Paton JY: Total energy expenditure and physical activity in young scottish children: mixed longitudinal study. Lancet. 2004, 363: 211-212. 10.1016/S0140-6736(03)15331-7.View ArticlePubMedGoogle Scholar
  16. Nomura K, Eto M, Kojima T, Ogawa S, Iijima K, Nakamura T, Araki A, Akishita M, Ouchi Y: Visceral fat accumulation and metabolic risk factor clustering in older adults. J Am Geriatr Soc. 2010, 58: 1658-1663. 10.1111/j.1532-5415.2010.03018.x.View ArticlePubMedGoogle Scholar
  17. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD: Epidemiology of sarcopenia among the elderly in new mexico. Am J Epidemiol. 1998, 147: 755-763. 10.1093/oxfordjournals.aje.a009520.View ArticlePubMedGoogle Scholar
  18. Doherty TJ: Invited review: aging and sarcopenia. J Appl Physiol. 2003, 95: 1717-1727.View ArticlePubMedGoogle Scholar
  19. Jurca R, Lamonte MJ, Barlow CE, Kampert JB, Church TS, Blair SN: Association of muscular strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc. 2005, 37: 1849-1855. 10.1249/01.mss.0000175865.17614.74.View ArticlePubMedGoogle Scholar
  20. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR: Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992, 85: 1364-1373. 10.1161/01.CIR.85.4.1364.View ArticlePubMedGoogle Scholar
  21. Wannamethee SG, Shaper AG, Lennon L, Whincup PH: Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr. 2007, 86: 1339-1346.PubMedGoogle Scholar
  22. Ruiz JR, Sui X, Lobelo F, Morrow JR, Jackson AW, Sjostrom M, Blair SN: Association between muscular strength and mortality in men: prospective cohort study. Br Med J. 2008, 337: a439-10.1136/bmj.a439.View ArticleGoogle Scholar
  23. Park SH, Park JH, Song PS, Kim DK, Kim KH, Seol SH, Kim HK, Jang HJ, Lee JG, Park HY, Park J, Shin KJ, Kim DI, Moon YS: Sarcopenic obesity as an independent risk factor of hypertension. J Am Soc Hypertens. 2013, in pressGoogle Scholar
  24. Taira S, Shimabukuro M, Higa M, Yabiku K, Kozuka C, Ueda R, Sunagawa S, Ohshiro Y, Doi M, Nanba T, Kawamoto E, Nakayama Y, Nakamura H, Iha T, Nakachi S, Tomoyose T, Ikema T, Yamakawa K, Masuzaki H: Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged japanese men with metabolic syndrome. Intern Med. 2013, 52: 1561-1571. 10.2169/internalmedicine.52.0521.View ArticlePubMedGoogle Scholar
  25. Shimabukuro M, Kozuka C, Taira S, Yabiku K, Dagvasumberel M, Ishida M, Matsumoto S, Yagi S, Fukuda D, Yamakawa K, Higa M, Soeki T, Yoshida H, Masuzaki H, Sata M: Ectopic fat deposition and global cardiometabolic risk: new paradigm in cardiovascular medicine. J Med Invest. 2013, 60: 1-14.View ArticlePubMedGoogle Scholar
  26. Reid KF, Naumova EN, Carabello RJ, Phillips EM, Fielding RA: Lower extremity muscle mass predicts functional performance in mobility-limited elders. J Nutr Health Aging. 2008, 12: 493-498. 10.1007/BF02982711.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M: Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010, 39: 412-423. 10.1093/ageing/afq034.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Heitmann BL, Frederiksen P: Thigh circumference and risk of heart disease and premature death: prospective cohort study. BMJ. 2009, 339: b3292-10.1136/bmj.b3292.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Yagi et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us